Key result
Pulsed field ablation yields similar 1-year AF freedom compared with cryoballoon ablation in obese patients.
Why the study?
The number of overweight and obese patients undergoing pulmonary vein isolation is increasing, but data on this population remain limited.
Does pulsed field ablation improve procedural parameters and provide similar 1-year freedom from atrial fibrillation compared to cryoballoon ablation in overweight and obese patients?
Cohort (n=115)
No
Does pulsed field ablation improve procedural parameters and provide similar 1-year freedom from atrial fibrillation compared to cryoballoon ablation in overweight and obese patients?
Hazard Ratio: 1.37 (95% CI 0.63–2.99)
Absolute Event Rate: 76% vs 76%
p-value: p=0.42
In overweight and obese patients with atrial fibrillation, pulsed field ablation provides comparable 1-year efficacy to cryoballoon ablation while significantly reducing procedural radiation exposure and contrast dye utilization.
PFA may reduce radiation versus CBA in overweight AF patients; observational data leave open randomized confirmation of comparable efficacy.
Pulmonary vein isolation (PVI) using pulsed field ablation (PFA) or cryoballoon ablation (CBA) are commonly used single-shot techniques for the treatment of patients with atrial fibrillation (AF). The number of overweight (BMI 25–30 kg/m 2 ) and obese (BMI>30 kg/m 2 ) patients undergoing PVI is increasing, but data on this patient population is limited. Consecutive AF patients with a BMI ≥25 kg/m 2 undergoing PFA- or CBA-PVI were included in this retrospective analysis. Baseline characteristics, procedural parameters and 1-year AF-freedom were retrospectively analyzed and compared for both ablation modalities. Of 115 patients (66 % men, 64 years [IQR: 58–71 years], 57 % overweight and 43 % obese) PFA- was performed in 68 % and CBA-PVI in 32 %. Contrast-dye volume (PFA: 80 ml [IQR: 60 − 117 ml] vs. CBA: 130 ml [IQR: 95 − 200 ml], P =0.001) and radiation exposure (PFA: 2196 cGy·cm 2 [IQR: 1398 − 2973 cGy·cm 2 ] vs. CBA: 3239 cGy·cm 2 [IQR: 1288 − 5062 cGy·cm 2 ], P =0.009) was lower in patients undergoing PFA-PVI. Logistic regression analysis identified obesity (OR: 5.58, 95 % CI: 1.63–19.06; P =0.006) and CBA-PVI (OR: 12.93, 95 % CI: 3.51–47.68; P < 0.001) to be associated with increased radiation exposure. Both techniques were comparably safe (PFA: 4 % vs. CBA: 0 %; P =0.3). The median follow-up time was 145 days [IQR: 103 − 294 days]. AF-freedom after 1-year was similar in overweight (82 %) and obese patients (67 %) (HR: 0.61; 95 % CI: 0.29–1.28; P =0.19) as well as in PFA- and CBA-PVI patients (76 % vs. 76 %, HR: 1.37; 95 % CI: 0.63–2.99; P =0.42). Overweight and obese patients undergoing PFA-PVI had lower contrast-dye volume compared to CBA-PVI. Obesity was associated with increased radiation exposure. Both techniques were comparably safe. The 1-year AF-freedom was similar in overweight and obese patients.
No takes yet. Share an insight, caveat, or question.
Jungen et al. (2024) conducted a cohort in Atrial fibrillation in overweight or obese patients (n=115). Pulsed field ablation vs. Cryoballoon ablation was evaluated on 1-year freedom from atrial fibrillation (HR 1.37, 95% CI 0.63-2.99, p=0.42). In overweight and obese patients with atrial fibrillation, pulsed field ablation was associated with similar 1-year freedom from atrial fibrillation compared to cryoballoon ablation (76% vs. 76%, HR 1.37, p=0.42).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: